Iron Path Capital, a private equity firm focused on healthcare and specialty industrials, has appointed Ted Clark as a partner to lead investment initiatives with a focus on high-quality businesses in the specialty industrials sector.
Clark joins Iron Path after stepping down as EVP and chief operating officer and transitioning to an advisory role with HB Fuller Company (NYSE: FUL), a global specialty chemical company founded in 1887. Clark joined HB Fuller following its 2017 acquisition of Royal Adhesives and Sealants (a platform Clark founded with Quad-C Management in 2003), where he served as president and CEO.
Iron Path Capital was founded in 2021 and has grown to nine investment professionals. The firm has made three platform investments in Emergence Health (urgent care), Versant Diagnostics (anatomic pathology) and Capitol Pain Institute (interventional pain management). Iron Path is a private equity sponsor focused on control buyouts in lower middle-market companies across the healthcare and specialty industrial sectors.
